Filing detail
ORAPHARMA INC S-1
Accession 0000950109-99-004697
Filed (ET)
Dec 29, 7:00 PM ET
Accepted
—
File size
1.3 MB
SEC accession
0000950109-99-004697
Filing details
- Company
- ORAPHARMA INC
- CIK
- 0001028065
- Incorporated
- DE
- Entity type
- operating
Related parties
- filerCIK 0001028065
Documents
S-1
FORM S-1 REGISTRATION STATEMENT
PrimaryOpen file ↗EX-4.1
SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
EX-4.2
WARRANT TO CANAAN VENTURES II LIMITED PARTNERSHIP
EX-4.3
WARRANT TO CANAAN VENTURES II OFFSHORE C.V.
EX-4.4
WARRANT TO CANAAN S.B.I.C., L.P.
EX-4.5
WARRANT TO CANAAN CAPITAL LIMITED PARTNERSHIP
EX-4.6
WARRANT TO CANAAN CAPITAL OFFSHORE LIMITED PARTNERSHIP
EX-4.9
SERIES D PREFERRED STOCK AGREEMENT
EX-4.10
RESTRICTED STOCK AGREEMENT
EX-4.11
RESTRICTED STOCK AGREEMENT
EX-4.12
STOCK WARRANT AGREEMENT
EX-4.13
RESTRICTED STOCK PURCHASE AGREEMENT
EX-10.1
1996 STOCK OPTION PLAN
EX-10.2
1999 EQUITY COMPENSATION PLAN
EX-10.5
CHILDREN'S HOSPITAL SPONSORED RESEARCH AGREEMENT
EX-10.6
EXCLUSIVE LICENSE AGREEMENT
EX-10.7
LICENSE AGREEMENT
EX-10.8
RESEARCH AND CONSULTING AGREEMENT
EX-10.9
LICENSE AGREEMENT
EX-10.10
LICENSE AGREEMENT WITH GARY R. JERNBERG
EX-10.11
LICENSE AGREEMENT
EX-23.1
CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
EX-23.3
CONSENT OF ARNALL, GOLDEN & GREGORY, LLP
EX-27
FINANCIAL DATA SCHEDULE